by

Emerres® – A low cost1—3, bioequivalent alternative to Levonelle 1500®4

  • Emerres® is an emergency contraceptive pill which contains 1.5 mg levonorgestrel3
  • Emerres® contains the same active ingredients and has demonstrated bioequivalence to Levonelle 1500®, therefore, following appropriate patient assessment and review, it may be prescribed in place of Levonelle 1500®4–6
  • Each pack of Emerres® contains a single tablet of emergency contraception7
Emerres-Levonorgestrel-1.5-mg-Tabs_Roundel
Clinical studies indicate that Emerres® may prevent 84–85% of expected pregnancies if taken within 72 hours of unprotected sexual intercourse.5

  • Emerres® emergency contraception should be offered after sexual intercourse if:
    • No form of contraception was used8
    • Regular hormonal contraception has been compromised or used incorrectly8
    • Barrier method failed8
  • NICE guideline states emergency contraception should be considered if a woman does not wish to conceive and has had unprotected sexual intercourse:8
    • On any day of a natural menstrual cycle
    • After regular hormonal contraception has been compromised or used incorrectly
    • From Day 21 after childbirth, unless all the lactational amenorrhea method (LAM) criteria are met
    • From Day 5 after miscarriage, abortion, ectopic pregnancy, or uterine evacuation for gestational trophoblastic disease
  • If vomiting occurs within 3 hours of taking the tablet, another tablet should be taken immediately5
  • After using emergency contraception it is recommended that patients use a local barrier method (e.g. condom, diaphragm, spermicide or cervical cap) until the next menstrual period starts5
  • The use of Emerres® does not contraindicate the continuation of regular hormonal contraception5

Please refer to the full Summary of Product Characteristics (SmPC) before prescribing.

Summary of Product Characteristics and Patient Information Leaflet
The links below will take you to the electronic Medicines Compendium (eMC). By clicking the links below you will leave the Morningside Healthcare Contraceptives website and be re-directed to an external site; Morningside Healthcare is not responsible for the content on external websites.

Please click here to access the Summary of Product Characteristics

Please click here to access the Patient Information Leaflet

Risk Minimisation Materials
The links below will take you to the electronic Medicines Compendium (eMC). By clicking the links below you will leave the Morningside Healthcare Contraceptives website and be re-directed to an external site; Morningside Healthcare is not responsible for the content on external websites.

Please click here to access the Patient Advice leaflet

Please click here to access a warning letter concerning the use of levonorgestrel-containing emergency hormonal contraception in users of hepatic-enzyme inducers

Additional Prescriber Resources
By clicking the link below you will leave the Morningside Healthcare Contraceptives website and be re-directed to an external site; Morningside Healthcare is not responsible for the content on external websites.

The full NICE Clinical Knowledge Summary for Emergency Contraception may be found here

 

References

  1. UK drug tariff (Accessed April 2024)
  2. NHS dm+d. Actual Medicinal Product (AMP) Emerres 1.5mg tablets (Morningside Healthcare Ltd). Available at: https://dmd-browser.nhsbsa.nhs.uk/amp/view/118815 (accessed January 2024);
  3. NHS dm+d. Actual Medicinal Product (AMP) Levonelle 15000microgram tablets (Bayer PLC). Available at: https://dmd-browser.nhsbsa.nhs.uk/amp/view/32845 (accessed January 2024);
  4. MHRA. UK PAR Emerres 1.5mg Tablet. December 2014. Available at: https://mhraproductsproduction.blob.core.windows.net/docs/0f60e25dbc2b59d4f5b28a5320b2664a18da6b7e (accessed January 2024);
  5. Morningside Healthcare Ltd. Emerres 1.5 mg tablet. February 2022. Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/9569/smpc (accessed January 2024);
  6. Bayer PLC. Levonelle 1500 microgram tablet. Summary of Product Characteristics. July 2021. Available at: https://www.medicines.org.uk/emc/medicine/16887/smpc (accessed January 2024);
  7. NHS dm+d. Actual Medicinal Product Pack (AMPP) Emerres 1.5mg tablets (Morningside Healthcare Ltd) 1 tablet. Available at: https://dmd-browser.nhsbsa.nhs.uk/ampp/view/138096 (accessed January 2024);
  8. NICE. Contraception – emergency. Available at: https://cks.nice.org.uk/contraception-emergency (accessed January 2024).

Levonelle 1500® chosen as a comparator as it is the license reference product for Emerres®.4

Filed Under: hcp, hcp-emerres